(Total Views: 875)
Posted On: 05/15/2023 12:15:01 PM
Post# of 72446
IPIX 10-Q is posted on OTCmarkets.com but has not yet been posted on the IPIX website. A couple of notes doing a very quick glance:
OS went from 488.3M shares on 2/15/23 to 514M shares as of 5/3/23 for an increase of 25.7M shares.
Cash on hand went from $2.42M on 12/31/22 to $1.94M on 3/31/23 for a quarterly spend rate of $483k. Cash on hand as of today’s filing is $1.7M with a budget of $1.9M over the next 12 months.
Alfasigma notified IPIX that they may delay the P2 B-UP/UPS study beyond the end of 2023.
JMHO – Whether shareholders like it or not, our investment in IPIX is dependent on the success of IPIX’s investment in BeaMedical. Leo appears to have throttled down spending to the lowest level in IPIX’s history with less than a $2M 12 month budget. I can only hope that Leo has allowed for enough runway to stretch the remaining cash on hand to cover expenses to a point in time where IPIX can start to monetize our investment in BeaMedical.
OS went from 488.3M shares on 2/15/23 to 514M shares as of 5/3/23 for an increase of 25.7M shares.
Cash on hand went from $2.42M on 12/31/22 to $1.94M on 3/31/23 for a quarterly spend rate of $483k. Cash on hand as of today’s filing is $1.7M with a budget of $1.9M over the next 12 months.
Alfasigma notified IPIX that they may delay the P2 B-UP/UPS study beyond the end of 2023.
JMHO – Whether shareholders like it or not, our investment in IPIX is dependent on the success of IPIX’s investment in BeaMedical. Leo appears to have throttled down spending to the lowest level in IPIX’s history with less than a $2M 12 month budget. I can only hope that Leo has allowed for enough runway to stretch the remaining cash on hand to cover expenses to a point in time where IPIX can start to monetize our investment in BeaMedical.
(8)
(0)
